The Effect of Ulcerative Colitis Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission After 12-Month Maintenance Treatment With MMx®,* Mesalamine

被引：0
|
作者：
Rubin, David T.
Inglis, Susi
Magee, Elizabeth
Streck, Paul
Solomon, Dory M.
D'Haens, Geert R.
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S770 / S770
页数：1
相关论文
共 50 条
  • [1] Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis
    D'Haens, Geert
    Sandborn, William J.
    Barrett, Karen
    Hodgson, Ian
    Streck, Paul
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07): : 1064 - 1077
  • [2] Mesalamine in the treatment and maintenance of remission of ulcerative colitis
    Ham, Maggie
    Moss, Alan C.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (02) : 113 - 123
  • [3] MMX™ mesalamine for the maintenance of remission in mild-to-moderate ulcerative colitis
    Sandborn, W.
    Kamm, M.
    Lichtenstein, G.
    Barrett, K.
    Joseph, R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S24 - S24
  • [4] Efficacy of MMX-mesalamine monotherapy for maintenance of remission in ulcerative colitis patients after mucosal healing
    Lopez-Diaz, J.
    Ferreiro, R.
    De la Iglesia, D.
    Lorenzo, A.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S336 - S337
  • [5] MMX™ mesalamine is effective for the maintenance of ulcerative colitis remission in both left-sided and extensive disease
    Lichtenstein, Gaiy R.
    Kamm, Michael A.
    Karlstadt, Robyn
    Diebold, Ron
    Barrett, Karen
    Joseph, Raymond E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S462 - S462
  • [6] Once- or twice-daily MMX™ mesalamine for the maintenance of remission of mild or moderate ulcerative colitis
    Panaccione, Remo
    Kamm, Michael A.
    Karlstadt, Robyn
    Diebold, Ron
    Barrett, Karen
    Joseph, Raymond E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S463 - S463
  • [7] Clinical and endoscopic remission with vedolizumab treatment in ulcerative colitis
    Almutairdi, A.
    Ma, C.
    Kotze, P. G.
    Al-Damarki, A.
    Devlin, S.
    Kaplan, G.
    Seow, C.
    Novak, K.
    Lu, C.
    Ferraz, J.
    Stewart, M.
    Buresi, M.
    Mathivanan, M.
    Jijon, H.
    Heatherington, J.
    Martin, M. -L.
    Panaccione, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S430 - S431
  • [8] Mesalamine versus azathioprine for maintenance treatment after steroid-induced remission in pediatric ulcerative colitis
    Sanchez Hernandez, D.
    Ruiz Hernandez, C.
    Muncunill, G. Pujol
    Varea Calderon, V.
    Martin de Carpi, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S397 - S397
  • [9] Maintenance of clinical remission with MMX® mesalamine 2.4g/day, irrespective of prior treatment, in patients with mild-to-moderate ulcerative colitis.
    Kane, S.
    Solomon, D.
    Palmen, M.
    Barrett, K.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S49 - S49
  • [10] Satisfaction with therapy among patients treated with MMX™ mesalamine for maintenance of remission in patients with mild-to-moderate ulcerative colitis
    Sandborn, W.
    Lichtenstein, G.
    Kamm, M.
    Barrett, K.
    Joseph, R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S24 - S24
12345